Sophia Genetics Sa (SOPH) Stock Price, Quote & News

Company Profile

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switze...

Industry: Health Information Services

Sector: Healthcare

Phone: 41 21 694 10 60

Website: www.sophiagenetics.com

Address:

La Pièce 12, Rolle, Switzerland

Bulltrader988 Jul. 10 at 7:17 PM

$SOPH still pounding the table here 👃👀

0 · Reply

Jnasty571 Jul. 10 at 12:01 PM

$SOPH jumpin in on this!

1 · Reply

Bulltrader988 Jul. 8 at 6:29 PM

$SOPH over $4 fun starts 👃👀

0 · Reply

Bulltrader988 Jul. 7 at 7:46 PM

$SOPH new hod into close 👃👀

0 · Reply

Bulltrader988 Jul. 7 at 6:49 PM

$SOPH forgot to post... 13 G was filled on 2025-06-27. AKRE CAPITAL MANAGEMENT, LLC owns 3,719,140 shares = 5.6 % ownership 👃👀 https://www.sec.gov/Archives/edgar/data/1112520/000091957425003801/xslSCHEDULE_13G_X01/primary_doc.xml

0 · Reply

Bulltrader988 Jul. 7 at 6:01 PM

$SOPH still pounding 👃👀

0 · Reply

Bulltrader988 Jul. 3 at 7:25 PM

$SOPH still pounding the table... Added today 👃👀

1 · Reply

Bulltrader988 Jul. 1 at 7:22 PM

$SOPH still here 👃👀

0 · Reply

Bulltrader988 Jun. 20 at 6:27 PM

$SOPH what a recovery intraday 👃👀

0 · Reply

_www_larval_com_ Jun. 20 at 3:42 PM

$SOPH just reverted 3% higher to -10% (~2Mv) a few minutes ago, 06/20 options, follow for more volatility.

0 · Reply

SOPHiA GENETICS SA (SOPH) Q1 2025 Earnings Call Transcript

May 6, 2025, 6:45 AM EDT - 2 months ago

SOPHiA GENETICS Reports First Quarter 2025 Results

Apr 28, 2025, 12:00 PM EDT - 2 months ago

SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR

AZN

Apr 22, 2025, 8:00 AM EDT - 2 months ago

SOPHiA GENETICS to Announce Financial Results for First Quarter 2025 on May 6, 2025

Apr 8, 2025, 2:00 AM EDT - 3 months ago

Precision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma Services with the SOPHiA DDM™ Platform and its Liquid Biopsy Capabilities

Mar 18, 2025, 9:00 AM EDT - 4 months ago

SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC

Mar 4, 2025, 2:32 PM EST - 4 months ago

SOPHiA GENETICS SA (SOPH) Q4 2024 Earnings Call Transcript

Mar 4, 2025, 6:45 AM EST - 4 months ago

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2024 Results

Feb 24, 2025, 4:00 AM EST - 4 months ago

Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing

AZN

Feb 18, 2025, 8:30 AM EST - 5 months ago

SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2024 on March 4, 2025

Jan 28, 2025, 8:46 AM EST - 5 months ago

SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities

Nov 21, 2024, 5:30 AM EST - 8 months ago

SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024

Nov 5, 2024, 2:46 PM EST - 8 months ago

SOPHiA GENETICS SA (SOPH) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 6:32 AM EST - 8 months ago

SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer

Nov 5, 2024, 6:30 AM EST - 8 months ago

SOPHiA GENETICS Reports Third Quarter 2024 Results

Oct 22, 2024, 6:45 AM EDT - 9 months ago

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2024 on November 5, 2024

Sep 14, 2024, 9:00 AM EDT - 10 months ago

SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024

Sep 12, 2024, 7:00 AM EDT - 10 months ago

SOPHiA GENETICS Announces Poster Presentations at ESMO 2024

Sep 12, 2024, 4:00 AM EDT - 10 months ago

SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024

Sep 10, 2024, 10:16 AM EDT - 10 months ago

SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing

AZN

Sep 5, 2024, 8:30 AM EDT - 11 months ago

SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024

Sep 4, 2024, 6:00 AM EDT - 11 months ago

SOPHiA GENETICS Unveils New Generation of the SOPHiA DDMTM Platform at Morgan Stanley Healthcare Conference 2024

Aug 28, 2024, 1:30 PM EDT - 11 months ago

SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth Conference

Aug 14, 2024, 3:00 AM EDT - 11 months ago

SOPHiA DDM™ Platform Certified Under IVDR

Aug 6, 2024, 6:45 AM EDT - 1 year ago

SOPHiA GENETICS Reports Second Quarter 2024 Results

Jul 29, 2024, 10:30 AM EDT - 1 year ago

SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™

Jul 24, 2024, 11:59 AM EDT - 1 year ago

SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix

Jul 24, 2024, 10:00 AM EDT - 1 year ago

SOPHiA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix

Jul 23, 2024, 6:45 AM EDT - 1 year ago

SOPHiA GENETICS to Announce Financial Results for Second Quarter 2024 on August 6, 2024

Jul 4, 2024, 2:30 AM EDT - 1 year ago

India-Based Dhiti Omics is Now Live on SOPHiA DDM™

Jun 24, 2024, 9:47 AM EDT - 1 year ago

SOPHiA GENETICS Publishes Results of 2024 Annual General Meeting

Jun 24, 2024, 2:00 AM EDT - 1 year ago

SOPHiA GENETICS Launches New Residual Acute Myeloid (RAM) Application

Jun 13, 2024, 6:00 AM EDT - 1 year ago

SOPHiA GENETICS Announces Kepler Uniklinikum is Live on SOPHiA DDM™ Platform

May 30, 2024, 12:19 PM EDT - 1 year ago

SOPHiA GENETICS Launches Global Consortium, SOPHiA UNITY, to Accelerate Cancer Research, Drug Development, and Data-Driven Patient Care

May 29, 2024, 10:00 AM EDT - 1 year ago

SOPHiA GENETICS to Launch New Whole Genome Sequencing Capabilities

May 20, 2024, 10:02 AM EDT - 1 year ago

SOPHiA GENETICS Announces Instituto Mário Penna as New Customer

May 16, 2024, 6:02 AM EDT - 1 year ago

Klinikum Klagenfurt am Wörthersee is Live with SOPHiA GENETICS

May 12, 2024, 2:46 AM EDT - 1 year ago

SOPHiA GENETICS SA (SOPH) Q1 2024 Earnings Call Transcript

May 7, 2024, 6:45 AM EDT - 1 year ago

SOPHiA GENETICS Reports First Quarter 2024 Results

Apr 30, 2024, 7:05 AM EDT - 1 year ago

SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference

Apr 23, 2024, 10:29 AM EDT - 1 year ago

SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024

Apr 23, 2024, 5:05 AM EDT - 1 year ago

SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa

Apr 17, 2024, 6:05 AM EDT - 1 year ago

SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)

Apr 4, 2024, 1:00 AM EDT - 1 year ago

SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership

Apr 2, 2024, 10:00 AM EDT - 1 year ago

Laboratorio Barnafi-Krause is Live on SOPHiA DDM™

Mar 20, 2024, 10:00 AM EDT - 1 year ago

SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada

Mar 15, 2024, 6:00 AM EDT - 1 year ago

SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear Collaboration

Mar 7, 2024, 12:07 PM EST - 1 year ago

SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare Conference

Mar 5, 2024, 10:46 AM EST - 1 year ago

SOPHiA GENETICS SA (SOPH) Q4 2023 Earnings Call Transcript

Mar 5, 2024, 6:45 AM EST - 1 year ago

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results

Bulltrader988 Jul. 10 at 7:17 PM

$SOPH still pounding the table here 👃👀

0 · Reply

Jnasty571 Jul. 10 at 12:01 PM

$SOPH jumpin in on this!

1 · Reply

Bulltrader988 Jul. 8 at 6:29 PM

$SOPH over $4 fun starts 👃👀

0 · Reply

Bulltrader988 Jul. 7 at 7:46 PM

$SOPH new hod into close 👃👀

0 · Reply

Bulltrader988 Jul. 7 at 6:49 PM

0 · Reply

Bulltrader988 Jul. 7 at 6:01 PM

$SOPH still pounding 👃👀

0 · Reply

Bulltrader988 Jul. 3 at 7:25 PM

$SOPH still pounding the table... Added today 👃👀

1 · Reply

Bulltrader988 Jul. 1 at 7:22 PM

$SOPH still here 👃👀

0 · Reply

Bulltrader988 Jun. 20 at 6:27 PM

$SOPH what a recovery intraday 👃👀

0 · Reply

_www_larval_com_ Jun. 20 at 3:42 PM

$SOPH just reverted 3% higher to -10% (~2Mv) a few minutes ago, 06/20 options, follow for more volatility.

0 · Reply

Bulltrader988 Jun. 17 at 6:59 PM

$SOPH 👀👀 https://www.tipranks.com/news/blurbs/sophia-genetics-soph-gets-a-buy-from-rbc-capital-blurbs?utm_source=webullapp.com&utm_medium=referral

0 · Reply

TUZZIE Jun. 3 at 7:07 PM

$SOPH Support at 3$? Time to add?

0 · Reply

Bulltrader988 May. 30 at 7:09 PM

$SOPH Holding strong 👀👀

0 · Reply

NOFAPGOD May. 30 at 4:53 PM

$SOPH Am in, Good Luck, hopefully $ARKK $ARKG will add you to their etf.

0 · Reply

Bulltrader988 May. 22 at 7:07 PM

$SOPH reminder 👀👀

0 · Reply

NOFAPGOD May. 14 at 3:49 AM

$SOPH A great company, insanely under valued, very under the radar, will go in hard next month.

0 · Reply

Bulltrader988 May. 13 at 8:38 AM

$SOPH 👀👀 https://www.tipranks.com/news/company-announcements/sophia-genetics-q1-2025-earnings-call-highlights?utm_source=webullapp.com&utm_medium=referral

0 · Reply

Bulltrader988 May. 6 at 11:01 AM

$SOPH 👀👀 https://www.stocktitan.net/news/SOPH/sop-hi-a-genetics-reports-first-quarter-2025-bqhhe24rf0ec.html

0 · Reply

Bulltrader988 May. 6 at 12:21 AM

$SOPH today before U.S. markets open 👀👀

0 · Reply

Bulltrader988 May. 3 at 7:44 PM

$SOPH next week 👀👀

0 · Reply

Bulltrader988 May. 2 at 3:45 PM

$SOPH 👀👀

0 · Reply

Bulltrader988 Apr. 28 at 4:20 PM

$SOPH 🤝🤝 $AZN 👀👀 https://www.stocktitan.net/news/SOPH/sop-hi-a-genetics-announces-expanded-collaboration-with-astra-zeneca-72zuplxffu5s.html

0 · Reply

Market Cap	250.08M
Revenue (ttm)	65.17M
Net Income (ttm)	-62.49M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-95.89%
Debt to Equity Ratio	0.16

Volume	27,300
Avg Vol	87,816
Day's Range	N/A - N/A
Shares Out	66.69M
Stochastic %K	69%
Beta	1.00
Analysts	Strong Sell
Price Target	$7.25